Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-12

Clinical Trial Update: Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System [NA]

View source ↗

Summary

A completed clinical trial evaluating optimization of nephroprotection with renin-angiotensin-aldosterone system inhibitors in chronic kidney disease patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Gdansk | Conditions: Chronic Kidney Disease, Proteinuria | NA | Status: COMPLETED